In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: AMERISAFE trades significantly below its PERT-weighted fair value of $72.42, indicating potential undervaluation with a 142.7% implied upside. Strong profitability and growth contrast with weaker liquidity and efficiency, while Monte Carlo analysis shows high volatility and a 16.7% downside risk below the current price. Valuation dispersion and scenario volatility reveal notable investment risk alongside opportunity.